Follow-up Study to Evaluate the Safety and Efficacy of FCN-159 in Pediatric Participants With Neurofibromatosis Type 1
Clinical trial NCT07024394 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07024394
- Sponsor
- Shanghai Fosun Pharmaceutical Industrial Development Co. Ltd.
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-06-12
- Primary completion
- 2029-09-23
- Enrollment
- 65
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.